saying that continuous glucose-ketone monitoring will be the key to bringing the incidence of DKA down. JDRF CEO Aaron Kowalski said the devices would also enable broader use of SGLT2 inhibitors ...
SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...
Ketosis is not dangerous and is not the same as ketoacidosis. When you are in ketosis, ketone bodies are produced indicating that your body has switched to fat metabolism rather than depending on ...